ImportRefusal LogoImportRefusal

Microlabs Ltd

⚠️ High Risk

FEI: 3011697796 • Sikkim • INDIA

FEI

FEI Number

3011697796

📍

Location

Sikkim

🇮🇳

Country

INDIA
🏢

Address

Mamring Nathang Rd South, , Sikkim, , India

High Risk

FDA Import Risk Assessment

69.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

12
Total Refusals
1
Unique Violations
11/13/2025
Latest Refusal
12/15/2017
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
41.3×30%
Recency
96.4×20%
Frequency
15.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7512×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
11/13/2025
60LCY01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/21/2025
62ODA18BISOPROLOL FUMARATE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/30/2024
60LDY01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/27/2024
61NCY99ANTI-DEPRESSANT N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/28/2023
60LDB01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/16/2023
60LDA01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/1/2021
61PDY55METFORMIN HCL (ANTI-DIABETIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/25/2021
62ODY14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/19/2020
62OCA39LABETALOL HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2019
60LCA01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/24/2019
62CCA99ANTI-HYPERTENSIVE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/15/2017
60LCA01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Microlabs Ltd's FDA import refusal history?

Microlabs Ltd (FEI: 3011697796) has 12 FDA import refusal record(s) in our database, spanning from 12/15/2017 to 11/13/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Microlabs Ltd's FEI number is 3011697796.

What types of violations has Microlabs Ltd received?

Microlabs Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Microlabs Ltd come from?

All FDA import refusal data for Microlabs Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.